Investigating protein-ligand interactions with a mutant FKBP possessing a designed specificity pocket

被引:72
作者
Yang, W [1 ]
Rozamus, LW [1 ]
Narula, S [1 ]
Rollins, CT [1 ]
Yuan, R [1 ]
Andrade, LJ [1 ]
Ram, MK [1 ]
Phillips, TB [1 ]
van Schravendijk, MR [1 ]
Dalgarno, D [1 ]
Clackson, T [1 ]
Holt, DA [1 ]
机构
[1] ARIAD Gen Therapeut, Cambridge, MA 02139 USA
关键词
D O I
10.1021/jm9904396
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Using structure-based design and protein mutagenesis we have remodeled the FKBP12 ligand binding site to include a sizable, hydrophobic specificity pocket. This mutant (F36V-FKBP) is capable of binding, with low or subnanomolar affinities, novel synthetic ligands possessing designed substituents that sterically prevent binding to the wild-type protein. Using binding and structural analysis of bumped compounds, we show here that the pocket is highly promiscuous-capable of binding a range of hydrophobic alkyl and aryl moieties with comparable affinity. Ligand affinity therefore appears largely insensitive to the degree of occupancy or quality of packing of the pocket. NMR spectroscopic analysis indicates that similar ligands can adopt radically different binding modes, thus complicating the interpretation of structure-activity relationships.
引用
收藏
页码:1135 / 1142
页数:8
相关论文
共 28 条
[1]   A versatile synthetic dimerizer for the regulation of protein-protein interactions [J].
Amara, JF ;
Clackson, T ;
Rivera, VM ;
Guo, T ;
Keenan, T ;
Natesan, S ;
Pollock, R ;
Yang, W ;
Courage, NL ;
Holt, DA ;
Gilman, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (20) :10618-10623
[2]   Molecular recognition of protein-ligand complexes: Applications to drug design [J].
Babine, RE ;
Bender, SL .
CHEMICAL REVIEWS, 1997, 97 (05) :1359-1472
[3]   RATIONAL DESIGN OF ORTHOGONAL RECEPTOR-LIGAND COMBINATIONS [J].
BELSHAW, PJ ;
SCHOEPFER, JG ;
LIU, KQ ;
MORRISON, KL ;
SCHREIBER, SL .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION IN ENGLISH, 1995, 34 (19) :2129-2132
[4]   Cell-specific calcineurin inhibition by a modified cyclosporin [J].
Belshaw, PJ ;
Schreiber, SL .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1997, 119 (07) :1805-1806
[5]   Design of allele-specific inhibitors to probe protein kinase signaling [J].
Bishop, AC ;
Shah, K ;
Liu, Y ;
Witucki, L ;
Kung, CY ;
Shokat, KM .
CURRENT BIOLOGY, 1998, 8 (05) :257-266
[6]   Generation of monospecific nanomolar tyrosine kinase inhibitors via a chemical genetic approach [J].
Bishop, AC ;
Kung, CY ;
Shah, K ;
Witucki, L ;
Shokat, KM ;
Liu, Y .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1999, 121 (04) :627-631
[7]  
Boehm H.-J., 1996, ANGEW CHEM INT EDIT, V35, P2588
[8]  
BRUNGER AT, 1992, XPLOR VERSION 3 1 SY
[9]   Redesigning small molecule-protein interfaces [J].
Clackson, T .
CURRENT OPINION IN STRUCTURAL BIOLOGY, 1998, 8 (04) :451-458
[10]   Redesigning an FKBP-ligand interface to generate chemical dimerizers with novel specificity [J].
Clackson, T ;
Yang, W ;
Rozamus, LW ;
Hatada, M ;
Amara, JF ;
Rollins, CT ;
Stevenson, LF ;
Magari, SR ;
Wood, SA ;
Courage, NL ;
Lu, XD ;
Cerasoli, F ;
Gilman, M ;
Holt, DA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (18) :10437-10442